AR122320A1 - TOPICAL COMPOSITIONS FOR THE RELIEF OF PAIN - Google Patents

TOPICAL COMPOSITIONS FOR THE RELIEF OF PAIN

Info

Publication number
AR122320A1
AR122320A1 ARP200102868A ARP200102868A AR122320A1 AR 122320 A1 AR122320 A1 AR 122320A1 AR P200102868 A ARP200102868 A AR P200102868A AR P200102868 A ARP200102868 A AR P200102868A AR 122320 A1 AR122320 A1 AR 122320A1
Authority
AR
Argentina
Prior art keywords
pain
relief
topical compositions
cannabinoid
compositions
Prior art date
Application number
ARP200102868A
Other languages
Spanish (es)
Original Assignee
Innocan Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innocan Pharma Ltd filed Critical Innocan Pharma Ltd
Priority to ARP200102868A priority Critical patent/AR122320A1/en
Publication of AR122320A1 publication Critical patent/AR122320A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En la presente invención se describen composiciones para uso tópico que comprenden agentes activos para proporcionar alivio del dolor. Las composiciones comprenden una sal de magnesio, un cannabinoide y al menos un agente analgésico tópico adicional. Adicionalmente, se describen métodos para el tratamiento del dolor, que comprenden la administración a una persona que lo necesite de una composición que comprende una cantidad farmacéuticamente efectiva de un cannabinoide, una sal de magnesio y, al menos, uno de salicilato de metilo y metanol.Compositions for topical use comprising active agents for providing pain relief are described herein. The compositions comprise a magnesium salt, a cannabinoid, and at least one additional topical analgesic agent. Additionally, methods for the treatment of pain are described, which comprise the administration to a person in need of a composition that comprises a pharmaceutically effective amount of a cannabinoid, a magnesium salt and, at least, one of methyl salicylate and methanol. .

ARP200102868A 2020-10-16 2020-10-16 TOPICAL COMPOSITIONS FOR THE RELIEF OF PAIN AR122320A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP200102868A AR122320A1 (en) 2020-10-16 2020-10-16 TOPICAL COMPOSITIONS FOR THE RELIEF OF PAIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP200102868A AR122320A1 (en) 2020-10-16 2020-10-16 TOPICAL COMPOSITIONS FOR THE RELIEF OF PAIN

Publications (1)

Publication Number Publication Date
AR122320A1 true AR122320A1 (en) 2022-08-31

Family

ID=83218722

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200102868A AR122320A1 (en) 2020-10-16 2020-10-16 TOPICAL COMPOSITIONS FOR THE RELIEF OF PAIN

Country Status (1)

Country Link
AR (1) AR122320A1 (en)

Similar Documents

Publication Publication Date Title
CO2021000174A2 (en) Topical compositions for pain relief
ES2553742T3 (en) Pharmaceutical dosage form comprising 6'-fluor- (N-methyl- or N, N-dimethyl) -4-phenyl-4 ', 9'-dihydro-3'H-spiro [cyclohexane-1,1'-pyran [3,4, b] indole] -4-amine
CL2017002939A1 (en) Topical pharmaceutical compositions
BR112020015688A8 (en) TOPICAL FORMULATIONS INCLUDING TOFACITINIB
AR048705A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II
AR060836A1 (en) A TRANS-MUCOSA DISK TO ADMINISTER AN ACTIVE AGENT, A TRANS-MUCOSA COMPOSITION AND THE METHOD OF ADMINISTRATION OBTAINED
AR054064A1 (en) COMPOSITION WITH ACTIVE PHARMACEUTICAL INGREDIENT BASED ON CANABINOID FOR IMPROVED DOSE FORMS
AR033808A1 (en) A TOPICAL COMPOSITION OF LOCAL ANESTHESIA AND THE PATCHES AND CONTAINERS CONTAINING IT
AR063109A1 (en) TOPICAL THERAPIES FOR ORAL MUCOSITIS AND OTHER AFFECTIONS
AR085662A1 (en) METHODS AND COMPOSITIONS TO TREAT HYPERURICEMIA AND METABOLIC DISORDERS ASSOCIATED WITH HYPERURICEMIA
CL2019002172A1 (en) Therapeutic agent for liver diseases.
CO6220945A2 (en) USE OF A COMPOSITION THAT INCLUDES FORMOTEROL AND DIPROPIANATE OF BECLOMETASONE FOR THE PREVENTION AND / OR TREATMENT OF AN EXAMERATION OF ASTHMA
PE20050144A1 (en) COMPOSITION TO IMPROVE COGNITIVE FUNCTIONS AND MEMORY
AR066666A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVING AGENT
AR048806A1 (en) USE OF CARIOFILENES IN THE PREPARATION OF MEDICINES AND TREATMENT OF BODY INFLAMMATION AND INFLAMMATORY PAIN AFFECTIONS
AR122320A1 (en) TOPICAL COMPOSITIONS FOR THE RELIEF OF PAIN
SV2006001916A (en) TRANSDERMAL PHARMACEUTICAL FORMULATIONS
CO2020001887A2 (en) Synergistic pharmaceutical combination of the active enantiomer s-ketorolac and gabapentin for the treatment of neuropathic pain
BRPI0416266A (en) method for treating, preventing and / or controlling an asbestos-related disease or disorder in a patient
CO6321156A2 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF SEXUAL TRANSMISSION INFECTIONS
AR048355A1 (en) ASSOCIATION BETWEEN A HETEROCICLICAL COMPOUND AND AN ANTIOXIDANT AGENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR067320A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS
AR045178A1 (en) USE OF A SELECTED RETINOID COMPONENT BETWEEN THE GROUP FORMED BY ACTIVE RETINOID AGENTS, PRETURSORS OF ACTIVE RETINOID AGENTS AND MIXTURES OF THE SAME, TO PREPARE A PHARMACEUTICAL COMPOSITION
CO5011042A1 (en) USE OF AN OXAZOLIDINONE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR TOPICAL ADMINISTRATION
AR063712A1 (en) TREATMENT OF PAIN USING SATRAPLATINO